MedTrace Logo

Knowledge and Practices of ADR Reporting in LMICs

NCT04301219 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1500

Last updated 2020-03-10

No results posted yet for this study

Summary

The reported literature suggests that knowledge about pharmacovigilance is on a lower side and ADR reporting is not common in developing countries. This survey may help us to identify the common gaps in knowledge and practices about pharmacovigilance so that we can devise the strategy on the basis of outcome.

Conditions

  • Adverse Reaction

Sponsors & Collaborators

  • Getz Pharma

    lead INDUSTRY

Principal Investigators

  • Mahwish Raza, Pharm-D · Shaheed Zulfiqar Ali Bhutto Medical University

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-04-01
Primary Completion
2018-03-01
Completion
2018-12-01

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04301219 on ClinicalTrials.gov